Literature DB >> 35287175

Infant brain tumor trials: Beyond feasibility.

Eric Bouffet1, Lucie Lafay-Cousin2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35287175      PMCID： PMC9248399          DOI： 10.1093/neuonc/noac065

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   13.029


× No keyword cloud information.
  9 in total

1.  Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03).

Authors:  Amar Gajjar; Giles W Robinson; Kyle S Smith; Tong Lin; Thomas E Merchant; Murali Chintagumpala; Anita Mahajan; Jack Su; Eric Bouffet; Ute Bartels; Tal Schechter; Tim Hassall; Thomas Robertson; Wayne Nicholls; Sridharan Gururangan; Kristin Schroeder; Michael Sullivan; Greg Wheeler; Jordan R Hansford; Stewart J Kellie; Geoffrey McCowage; Richard Cohn; Michael J Fisher; Matthew J Krasin; Clinton F Stewart; Alberto Broniscer; Ivo Buchhalter; Ruth G Tatevossian; Brent A Orr; Geoff Neale; Paul Klimo; Frederick Boop; Ashok Srinivasan; Stefan M Pfister; Richard J Gilbertson; Arzu Onar-Thomas; David W Ellison; Paul A Northcott
Journal:  J Clin Oncol       Date:  2021-01-06       Impact factor: 44.544

2.  Excellent outcome of young children with nodular desmoplastic medulloblastoma treated on "Head Start" III: a multi-institutional, prospective clinical trial.

Authors:  Girish Dhall; Sharon H O'Neil; Lingyun Ji; Kelley Haley; Ashley M Whitaker; Marvin D Nelson; Floyd Gilles; Sharon L Gardner; Jeffrey C Allen; Albert S Cornelius; Kamnesh Pradhan; James H Garvin; Randal S Olshefski; Juliette Hukin; Melanie Comito; Stewart Goldman; Mark P Atlas; Andrew W Walter; Stephen Sands; Richard Sposto; Jonathan L Finlay
Journal:  Neuro Oncol       Date:  2020-12-18       Impact factor: 12.300

3.  Clinical phenotypes and prognostic features of embryonal tumours with multi-layered rosettes: a Rare Brain Tumor Registry study.

Authors:  Sara Khan; Palma Solano-Paez; Tannu Suwal; Mei Lu; Salma Al-Karmi; Ben Ho; Iqra Mumal; Mary Shago; Lindsey M Hoffman; Andrew Dodgshun; Sumihito Nobusawa; Uri Tabori; Ute Bartels; David S Ziegler; Jordan R Hansford; Vijay Ramaswamy; Cynthia Hawkins; Christelle Dufour; Nicolas André; Eric Bouffet; Annie Huang
Journal:  Lancet Child Adolesc Health       Date:  2021-09-30

4.  Vorinostat and isotretinoin with chemotherapy in young children with embryonal brain tumors: A report from the Pediatric Brain Tumor Consortium (PBTC-026).

Authors:  Sarah E S Leary; Lindsay Kilburn; J Russell Geyer; Mehmet Kocak; Jie Huang; Kyle S Smith; Jennifer Hadley; Ralph Ermoian; Tobey J MacDonald; Stewart Goldman; Peter Phillips; Tina Young Poussaint; James M Olson; David W Ellison; Ira J Dunkel; Maryam Fouladi; Arzu Onar-Thomas; Paul A Northcott
Journal:  Neuro Oncol       Date:  2022-07-01       Impact factor: 13.029

5.  Clinical, Pathological, and Molecular Characterization of Infant Medulloblastomas Treated with Sequential High-Dose Chemotherapy.

Authors:  Lucie Lafay-Cousin; Amy Smith; Susan N Chi; Elizabeth Wells; Jennifer Madden; Ashley Margol; Vijay Ramaswamy; Jonathan Finlay; Michael D Taylor; Girish Dhall; Douglas Strother; Mark W Kieran; Nicholas K Foreman; Roger J Packer; Eric Bouffet
Journal:  Pediatr Blood Cancer       Date:  2016-05-04       Impact factor: 3.167

6.  Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial.

Authors:  Giles W Robinson; Vasilisa A Rudneva; Ivo Buchhalter; Catherine A Billups; Sebastian M Waszak; Kyle S Smith; Daniel C Bowers; Anne Bendel; Paul G Fisher; Sonia Partap; John R Crawford; Tim Hassall; Daniel J Indelicato; Frederick Boop; Paul Klimo; Noah D Sabin; Zoltan Patay; Thomas E Merchant; Clinton F Stewart; Brent A Orr; Jan O Korbel; David T W Jones; Tanvi Sharma; Peter Lichter; Marcel Kool; Andrey Korshunov; Stefan M Pfister; Richard J Gilbertson; Robert P Sanders; Arzu Onar-Thomas; David W Ellison; Amar Gajjar; Paul A Northcott
Journal:  Lancet Oncol       Date:  2018-05-16       Impact factor: 41.316

7.  Nonmetastatic Medulloblastoma of Early Childhood: Results From the Prospective Clinical Trial HIT-2000 and An Extended Validation Cohort.

Authors:  Martin Mynarek; Katja von Hoff; Torsten Pietsch; Holger Ottensmeier; Monika Warmuth-Metz; Brigitte Bison; Stefan Pfister; Andrey Korshunov; Tanvi Sharma; Natalie Jaeger; Marina Ryzhova; Olga Zheludkova; Andrey Golanov; Elisabeth Jane Rushing; Martin Hasselblatt; Arend Koch; Ulrich Schüller; Andreas von Deimling; Felix Sahm; Martin Sill; Markus J Riemenschneider; Hildegard Dohmen; Camelia Maria Monoranu; Clemens Sommer; Ori Staszewski; Christian Mawrin; Jens Schittenhelm; Wolfgang Brück; Katharina Filipski; Christian Hartmann; Matthias Meinhardt; Klaus Pietschmann; Christine Haberler; Irene Slavc; Nicolas U Gerber; Michael Grotzer; Martin Benesch; Paul Gerhardt Schlegel; Frank Deinlein; André O von Bueren; Carsten Friedrich; Björn-Ole Juhnke; Denise Obrecht; Gudrun Fleischhack; Robert Kwiecien; Andreas Faldum; Rolf Dieter Kortmann; Marcel Kool; Stefan Rutkowski
Journal:  J Clin Oncol       Date:  2020-04-24       Impact factor: 44.544

8.  Children's Oncology Group Phase III Trial of Reduced-Dose and Reduced-Volume Radiotherapy With Chemotherapy for Newly Diagnosed Average-Risk Medulloblastoma.

Authors:  Jeff M Michalski; Anna J Janss; L Gilbert Vezina; Kyle S Smith; Catherine A Billups; Peter C Burger; Leanne M Embry; Patricia L Cullen; Kristina K Hardy; Scott L Pomeroy; Johnnie K Bass; Stephanie M Perkins; Thomas E Merchant; Paul D Colte; Thomas J Fitzgerald; Timothy N Booth; Joel M Cherlow; Karin M Muraszko; Jennifer Hadley; Rahul Kumar; Yuanyuan Han; Nancy J Tarbell; Maryam Fouladi; Ian F Pollack; Roger J Packer; Yimei Li; Amar Gajjar; Paul A Northcott
Journal:  J Clin Oncol       Date:  2021-06-10       Impact factor: 50.717

9.  Efficacy of Carboplatin and Isotretinoin in Children With High-risk Medulloblastoma: A Randomized Clinical Trial From the Children's Oncology Group.

Authors:  Sarah E S Leary; Roger J Packer; Yimei Li; Catherine A Billups; Kyle S Smith; Alok Jaju; Linda Heier; Peter Burger; Karin Walsh; Yuanyuan Han; Leanne Embry; Jennifer Hadley; Rahul Kumar; Jeff Michalski; Eugene Hwang; Amar Gajjar; Ian F Pollack; Maryam Fouladi; Paul A Northcott; James M Olson
Journal:  JAMA Oncol       Date:  2021-09-01       Impact factor: 33.006
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.